Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch
- Resource Type
- Short Communication
- Source
- In
The Journal of Allergy and Clinical Immunology April 2016 137(4):1258-1261 - Subject
- Language
- ISSN
- 0091-6749